Lastly, to increase the relevance of our animal research findings to patients, we plan to measure SPLUNC1 and PA in sputum and BAL samples from CF and COPD patients treated with A1AT or placebo. This evidence concerns the gene BPIFA1 and chronic obstructive pulmonary disease.